CombiGene
Founded 2008
Sweden
13 employees
Post Ipo Equity
Biotechnology, Health and Wellness +1
Sweden
13 employees
Post Ipo Equity
Biotechnology, Health and Wellness +1
General Information
Get notified when CombiGene moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CombiGene
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Sweden Market
Biotechnology
About CombiGene
No funding data available for CombiGene yet.
Get notified when CombiGene raises fundingCombiGene Alternatives & Competitors
CombiGene vs
Diagonal Bio
Sweden
Pathogen diagnostics with unprecedented speed, accuracy and ease
10 employees
Biotechnology, Health Care
CombiGene vs
Abliva AB
Sweden
Delivering mitochondrial health
Post Ipo Equity
12 employees
Biotechnology, Health Care
CombiGene vs
EndoDrill® biopsy instruments for early and accurate cancer diagnostics.
Series Unknown
12 employees
Health Care, Medical Devices
FAQ About CombiGene
CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies unde...
CombiGene was founded in 2008.
CombiGene is headquartered in Sweden.
CombiGene operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
CombiGene has approximately 13 employees.
Top alternatives and competitors to CombiGene include Diagonal Bio, Abliva AB, BiBBInstruments AB, PolarCool AB (publ), Sol Voltaics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CombiGene and Diagonal Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors CombiGene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.